"b cell non hodgkins lymphoma" trang 1 - tải miễn phí từ tailieuXANH
Clinical significance of BCL2, C-MYC, and BCL6 genetic abnormalities, epstein barr virus infection, CD5 protein expression, germinal center B cell non germinal center B cell subtypes, Co-expression of MYC/BCL2 proteins and Co-expression of MYC/BCL2/BCL6 proteins in diffuse large B-cell lymphoma: A clinical and pathological correlation study of 120 patients

Clinical significance of BCL2, C-MYC, and BCL6 genetic abnormalities, epstein barr virus infection, CD5 protein expression, germinal center B cell non germinal center B cell subtypes, Co-expression of MYC/BCL2 proteins and Co-expression of MYC/BCL2/BCL6 proteins in diffuse large B-cell lymphoma: A clinical and pathological correlation study of 120 patients
11    138    0
P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma

P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma
12    48    0
Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma

Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma
8    57    0
Clinical and prognostic features of non hodgkin lymphoma and preliminary effective evaluation of R-chop regimen in patients with diffuse large B-cell lymphoma

Clinical and prognostic features of non hodgkin lymphoma and preliminary effective evaluation of R-chop regimen in patients with diffuse large B-cell lymphoma
8    50    1
Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelialmesenchymal transition signature and longer survival in squamous cell lung carcinoma

Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelialmesenchymal transition signature and longer survival in squamous cell lung carcinoma
10    62    0
Non-traumatic splenic rupture - a rare first presentation of diffuse large B-cell lymphoma and a review of the literature

Non-traumatic splenic rupture - a rare first presentation of diffuse large B-cell lymphoma and a review of the literature
6    59    0
Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)

Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)
11    37    1
Single-cell transcriptome and antigenimmunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer

Single-cell transcriptome and antigenimmunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer
21    134    1
Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma
9    50    0
TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP
7    85    0
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma

Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
7    78    0
Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation

Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation
13    62    0
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: A prospective, multicentre, non-interventional study

Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: A prospective, multicentre, non-interventional study
10    64    0
Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: Long-term results from a single center in China

Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: Long-term results from a single center in China
11    56    0
Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: A population-based analysis

Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: A population-based analysis
11    55    0
Low incidence of ABL-class and JAK-STAT signaling pathway alterations in uniformly treated pediatric and adult B-cell acute lymphoblastic leukemia patients using MRD risk-directed approach – a populationbased study

Low incidence of ABL-class and JAK-STAT signaling pathway alterations in uniformly treated pediatric and adult B-cell acute lymphoblastic leukemia patients using MRD risk-directed approach – a populationbased study
12    50    1
Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring

Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring
14    148    1
Prognostic significance of pretreatment serum free fatty acid in patients with diffuse large B-cell lymphoma in the rituximab era: A retrospective analysis

Prognostic significance of pretreatment serum free fatty acid in patients with diffuse large B-cell lymphoma in the rituximab era: A retrospective analysis
9    52    1
Primary diffuse large B-cell lymphoma presenting as a chest wall mass: A case report

Primary diffuse large B-cell lymphoma presenting as a chest wall mass: A case report
6    135    1
A study of pathological characteristics of pediatric non-Hodgkin lymphoma based on 2008 version of the world health organization classification of lymphoid neoplasms at children’s hospital 1

A study of pathological characteristics of pediatric non-Hodgkin lymphoma based on 2008 version of the world health organization classification of lymphoid neoplasms at children’s hospital 1
7    49    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.